Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Hypercoagulable Disorders in Orthopaedics: Etiology, Considerations, and Management
David Romano1, Maxwell Boyle2, Alexander E Isla2
1Riverside Regional Medical Center, Newport News, Virginia.
Hypercoagulable disorders (HCDs) increase venous thromboembolic event (VTE) risk. Avoid tourniquets in HCD patients during surgery, and monitor closely if their HCD status is unknown.
Area of Science:
- Hematology
- Vascular Surgery
- Thrombosis Research
Background:
- Hypercoagulable disorders (HCDs), both inherited and acquired, elevate the risk of venous thromboembolic events (VTEs).
- Diagnosis of HCDs frequently occurs postoperatively due to surgical complications, highlighting a gap in proactive identification.
- The use of tourniquets in orthopedic surgery for patients with HCDs remains poorly understood and debated.
Purpose of the Study:
- To review the implications of hypercoagulable disorders in surgical patients.
- To provide recommendations regarding tourniquet use in orthopedic surgery for patients with known or suspected HCDs.
Main Methods:
- Literature review and clinical consensus on hypercoagulable disorders and surgical management.
- Analysis of existing data and case reports concerning tourniquet application in patients with thrombotic tendencies.
Main Results:
- Hypercoagulable disorders significantly increase the risk of VTEs, often identified after surgical procedures.
- Tourniquet use in patients with HCDs is associated with potential complications and requires careful consideration.
- Proactive hematological consultation is crucial for patients with known or suspected HCDs.
Conclusions:
- Referral to hematological specialists is recommended for HCD workup and management.
- Tourniquets should be avoided in surgical settings for patients with HCDs whenever feasible.
- Vigilant postoperative monitoring is essential for patients undergoing surgery with tourniquets, especially when HCD status is uncertain.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management

